Ankam, Inc. (ANKM)

Executive Summary

Ankam, Inc. (OTC: ANKM) is a very small technology company, incorporated in 2018 and linked to Taiwan through its operations, that develops consumer mobile applications for personal finance and currency conversion, and has recently expanded into selling health products through a subsidiary in Asia-Pacific markets. The company is tiny by any measure: a single listed officer/employee (CEO Wen Lung Wang), fiscal 2025 revenue of about $325,000 (up from roughly $104,450 in fiscal 2024), and disclosed going-concern doubt in its recent SEC filings.

Core Business Model & How They Work

Ankam develops and monetizes consumer mobile applications — Expense Minder (an expense-tracking and budgeting app), MoneySaverApp (held via subsidiary Ankam LLC), and Apex Currency Converter (acquired January 2024) — and, since August 2024, has expanded into selling health products through its Mei Sheng Corporation Limited subsidiary, which now generates most of the company's revenue from Asia-Pacific operations.

Product Portfolio

• Expense Minder: expense tracking, categorization, savings goals, and bill reminders
• MoneySaverApp: budgeting/savings app held via Ankam LLC
• Apex Currency Converter: currency conversion tool
• Health-products sales platform operated through Mei Sheng Corporation Limited (Asia-Pacific)

Competitive Landscape

In personal-finance apps, Ankam competes against far larger, well-funded incumbents (Rocket Money, YNAB, PocketGuard, and bank-embedded budgeting tools). In currency conversion, it competes with established tools such as XE and Wise. In health products, it competes against a large field of regional e-commerce and direct-sales health and wellness distributors across Asia-Pacific. Ankam has no differentiated technology or brand recognition relative to any of these established players.

Strategic Strengths & Risks

Strengths: Revenue roughly tripled year over year (from ~$104,450 to ~$325,000), and the pivot into health-product sales via Mei Sheng gave the company its first meaningful revenue stream. Risks: Going-concern doubt disclosed in recent filings, extremely thin operations (essentially one executive running the company), no meaningful competitive differentiation in crowded personal-finance-app and health-e-commerce categories, a small and illiquid OTC-traded float with limited disclosure, and total dependence on a single individual for strategy and execution.

Financial Overview

• Fiscal 2025 revenue: ~$325,000 (fiscal 2024: ~$104,450)
• Going-concern qualification disclosed in recent SEC filings
• Minimal balance sheet scale typical of an OTC micro-cap; no meaningful market-cap or analyst coverage data found

Summary Conclusion

Ankam is a pre-scale, single-executive OTC micro-cap with early, largely undifferentiated products across personal-finance apps and Asia-Pacific health-product sales. Its going-concern status and near-total lack of competitive differentiation make it one of the weakest business-quality profiles reviewed here.